Meningiomas are mostly regarded as benign tumours, accounting for 13% to 26% of all primary intracranial tumors1. According to 2016 World Health Organization (WHO) classification, meningiomas are classified into grade I (benign), II (atypical), and III (anaplastic).2 Meningioma are neoplasms derived from arachnoidal (meningothelial) cells. These lesions can occur in people of any age but commonly present in middle age. Women are more likely to develop a meningioma, with a female/male ratio of approximately 2:1 intracranially and 10:1 in the spine.3 Even after complete removal, meningiomas have been estimated to recur in 10 to 32% of the cases within 10 years. However, recurrences in grade 1 meningiomas are rare and occur after long dur...
Background: Meningiomas are common benign tumors of the brain. Meningioma patients have optimal func...
Meningiomas represent the most common primary brain tumor and comprise 3 World Health Organization (...
International audienceIt is not known how long it takes from the initial neoplastic transformation o...
Meningioma accounts for more than 30% of all intracranial tumours. It affects mainly the elderly abo...
Meningiomas are tumours that arise from the meningothelial cells. Most of these tumours are intracra...
This short report presents a case that developed rapid recurrence of a malignant meningioma. The men...
Background:The dura mater, arachnoid mater and pia mater are layers of meninges surrounding brain an...
Meningiomas are among the most common central nervous system (CNS) tumors worldwide. These extra-axi...
Meningiomas are common primary central nervous system tumors derived from the meninges, with managem...
Meningiomas are the most the common primary brain tumors in adults, representing approximately a thi...
Objective The aim of the study is to determine which clinic, radiologic, and surgical characteristic...
Objective: Atypical meningioma are an intermediate group of meningiomas, exhibiting less favourable ...
BACKGROUND Prognostic markers for meningioma recurrence are needed to guide patient management. Apar...
International audiencePatients with surgery- and radiation-refractory meningiomas have a poor outcom...
Meningiomas are considered a substantially benign disease that can be treated surgically in the vast...
Background: Meningiomas are common benign tumors of the brain. Meningioma patients have optimal func...
Meningiomas represent the most common primary brain tumor and comprise 3 World Health Organization (...
International audienceIt is not known how long it takes from the initial neoplastic transformation o...
Meningioma accounts for more than 30% of all intracranial tumours. It affects mainly the elderly abo...
Meningiomas are tumours that arise from the meningothelial cells. Most of these tumours are intracra...
This short report presents a case that developed rapid recurrence of a malignant meningioma. The men...
Background:The dura mater, arachnoid mater and pia mater are layers of meninges surrounding brain an...
Meningiomas are among the most common central nervous system (CNS) tumors worldwide. These extra-axi...
Meningiomas are common primary central nervous system tumors derived from the meninges, with managem...
Meningiomas are the most the common primary brain tumors in adults, representing approximately a thi...
Objective The aim of the study is to determine which clinic, radiologic, and surgical characteristic...
Objective: Atypical meningioma are an intermediate group of meningiomas, exhibiting less favourable ...
BACKGROUND Prognostic markers for meningioma recurrence are needed to guide patient management. Apar...
International audiencePatients with surgery- and radiation-refractory meningiomas have a poor outcom...
Meningiomas are considered a substantially benign disease that can be treated surgically in the vast...
Background: Meningiomas are common benign tumors of the brain. Meningioma patients have optimal func...
Meningiomas represent the most common primary brain tumor and comprise 3 World Health Organization (...
International audienceIt is not known how long it takes from the initial neoplastic transformation o...